NLS Acquisition

Atos Medical has announced the acquisition of the German tracheostomy company TRACOE medical, including NL-based MC Europe and of UK-based Kapitex Healthcare. “I am truly excited that TRACOE, MC Europe and Kapitex will join the Atos family. We share a strong vision of making life easier for people living with a neck stoma and we […]

AstraZeneca’s Alexion has exercised its option to acquire all remaining equity in Caelum Biosciences for CAEL-101, a potentially first-in-class fibril-reactive monoclonal antibody (mAb) for the treatment of light chain (AL) amyloidosis. CAEL-101 is currently being evaluated in the Cardiac Amyloid Reaching for Extended Survival (CARES) Phase III clinical programme in combination with standard-of-care (SoC) therapy […]

Aegirbio acquires the health tech company Dynamic Code, and states that it is now embarking on the strategic construction of an international operator in the rapidly evolving domain of e-health. Dynamic Code is a health tech company with its registered office in Linköping, offering diagnostic and health-test solutions to healthcare and directly to the consumer […]

Elekta has acquired its long-time partner and Turkish distributor of neurosurgery solutions, Özyürek Mümessillik ve Dış Ticaret A.Ş. The acquisition will improve Elekta’s market access in the region and strengthen its relationship with customers, it states. “For the past 30 years, Özyürek A.Ş. helped establish Leksell Gamma Knife in Turkey and the region with several […]

Investor AB has undertaken to accept the public offer made September 2, by Agnafit Bidco for the shares in Swedish Orphan Biovitrum at a price per share of SEK 235. Investor owns 107.6 million shares in Sobi, representing 35.4 percent of the capital and votes. The offer values Investor’s shares in Sobi at SEK 25.3 […]

BICO has acquired all outstanding shares in Advanced BioMatrix, an American company focusing on 3D research applications. The Advanced BioMatrix portfolio includes collagen bioinks, high purity extracellular matrix proteins, chemically modified proteins and polysaccharides, and other reagents and cell assays, sold to research institutions, and pharmaceutical and biotech companies. The company has a particularly strong […]